Recon: BMS plans $2.3B Houston manufacturing site; MHRA approves Lilly weight-loss drug for weight loss, type 2 diabetes
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
10 Aug 2026 IMDRF details key principles for regulators to adopt PCCPs The International Medical Device Regulators Forum (IMDRF) has finalized a technical document outlining how regulatory agencies may adopt predetermined change control plans (PCCP). The document lists principles for regulators to consider when developing their own PCCP regulations, as well as key elements to include in manufacturers' PCCPs. Regulatory News
comments(0)
5-min edit window · permanent after that